Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,737 | 279 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,410 | 208 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $400.88 | 25 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $363.21 | 21 | $0 (2020) |
| Lilly USA, LLC | $176.43 | 11 | $0 (2020) |
| Actelion Pharmaceuticals US, Inc. | $100.00 | 1 | $0 (2019) |
| Medtronic USA, Inc. | $83.36 | 1 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $55.44 | 3 | $0 (2020) |
| Medtronic MiniMed, Inc. | $28.88 | 2 | $0 (2017) |
| Abbott Laboratories | $22.38 | 1 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $20.30 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $19.84 | 1 | Novo Nordisk Inc ($19.84) |
| 2020 | $452.08 | 40 | Novo Nordisk Inc ($311.85) |
| 2019 | $1,093 | 81 | Novo Nordisk Inc ($561.88) |
| 2018 | $1,147 | 86 | Novo Nordisk Inc ($771.48) |
| 2017 | $1,025 | 71 | Novo Nordisk Inc ($745.43) |
All Payment Transactions
279 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/30/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Diabetes | ||||||
| 11/13/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Diabetes | ||||||
| 11/11/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Diabetes | ||||||
| 11/06/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: Diabetes | ||||||
| 10/30/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: Diabetes | ||||||
| 10/22/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Diabetes | ||||||
| 10/22/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $3.40 | General |
| Category: Diabetes | ||||||
| 10/20/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $3.08 | General |
| Category: Diabetes | ||||||
| 10/09/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: Diabetes | ||||||
| 09/30/2020 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $21.34 | General |
| Category: Diabetes | ||||||
| 09/26/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: Diabetes | ||||||
| 09/03/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Diabetes | ||||||
| 09/03/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $3.93 | General |
| Category: Diabetes | ||||||
| 08/28/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $4.69 | General |
| Category: Diabetes | ||||||
| 08/14/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $4.07 | General |
| Category: Diabetes | ||||||
| 08/14/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $3.69 | General |
| Category: Diabetes | ||||||
| 08/13/2020 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Diabetes | ||||||
| 08/13/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: Diabetes | ||||||
| 08/07/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $2.69 | General |
| Category: Diabetes | ||||||
| 08/04/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/30/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Diabetes | ||||||
| 07/21/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Diabetes | ||||||
| 06/19/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Diabetes | ||||||
| 06/11/2020 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 37 | 37 | $3,908 | $485.97 |
| 2020 | 8 | 370 | 577 | $71,705 | $20,848 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 25 | $2,888 | $271.91 | 9.4% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 12 | 12 | $1,021 | $214.06 | 21.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 102 | 179 | $31,012 | $10,730 | 34.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 102 | 208 | $24,024 | $7,628 | 31.8% |
| 90653 | Vaccine for influenza for injection into muscle | Office | 2020 | 17 | 17 | $1,517 | $1,012 | 66.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 26 | 38 | $3,232 | $769.73 | 23.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 17 | 17 | $803.25 | $290.19 | 36.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 19 | 19 | $2,155 | $209.42 | 9.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 51 | 60 | $1,386 | $178.92 | 12.9% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2020 | 36 | 39 | $7,576 | $29.08 | 0.4% |
About Dr. Abilio Munoz, MD
Dr. Abilio Munoz, MD is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154498228.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Abilio Munoz, MD has received a total of $3,737 in payments from pharmaceutical and medical device companies, with $19.84 received in 2021. These payments were reported across 279 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($3,737).
As a Medicare-enrolled provider, Munoz has provided services to 407 Medicare beneficiaries, totaling 614 services with total Medicare billing of $21,334. Data is available for 2 years (2020–2021), covering 10 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 11/30/2006
- Last Updated 02/09/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1154498228
Products in Payments
- Victoza (Drug) $795.86
- Ozempic (Drug) $634.41
- Tresiba (Drug) $469.39
- Xultophy 100/3.6 (Drug) $323.65
- FARXIGA (Drug) $292.90
- TOUJEO (Drug) $213.99
- SYMBICORT (Drug) $107.98
- SOLIQUA (Drug) $87.69
- NUVENT (Device) $83.36
- JARDIANCE (Drug) $83.07
- TRULICITY (Drug) $80.46
- SOLIQUA 100/33 (Drug) $50.03
- Saxenda (Drug) $42.14
- iPro2 (Device) $28.88
- STIOLTO (Drug) $24.98
- Octrode SCS Leads (Device) $22.38
- XARELTO (Drug) $20.30
- BYSTOLIC (Drug) $19.01
- MYRBETRIQ (Drug) $17.86
- TRADJENTA (Drug) $16.99
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768